See what CanVECTOR members are publishing to advance the field of venous thromboembolism
Publications since 2016 that are linked to venous thromboembolism and/or anticoagulant therapy

Publications for Peter Gross

Updated daily

Back to Member List

#	PubMedId	Deleted	Publication
	37910528	0	Shaw JR, James T, Douxfils J, et al. Thrombin generation, bleeding and hemostasis in humans: Protocol for a scoping review of the literature. PLoS One. 2023 Nov 1;18(11):e0293632. doi: 10.1371/journal.pone.0293632. eCollection 2023.
	37907305	0	Makedonov I, Kahn S, Abdulrehman J, et al. TILE pilot trial study protocol: Tinzaparin Lead-in to Prevent the Post-Thrombotic syndrome study protocol. BMJ Open. 2023 Oct 31;13(10):e064715. doi: 10.1136/bmjopen-2022-064715.
	37850360	0	Lun R, Cerasuolo JO, Carrier M, et al. Previous Ischemic Stroke Significantly Alters Stroke Risk in Newly Diagnosed Cancer Patients. Stroke. 2023 Oct 18. doi: 10.1161/STROKEAHA.123.042993.
	37751849	0	Chessum JE, Shaya SA, Rajab D, et al. Thrombin-activatable fibrinolysis inhibitor and sex modulate thrombus stability and pulmonary embolism burden in a murine model. J Thromb Haemost. 2023 Sep 24:S1538-7836(23)00718-3. doi: 10.1016/j.jtha.2023.09.016.
	37438219	0	Karkouti K, Gross PL. What can ex vivo experiments contribute to clinical haemostasis management? Br J Anaesth. 2023 Sep;131(3):424-425. doi: 10.1016/j.bja.2023.06.041. Epub 2023 Jul 10.
	37144115	0	Carlin S, Gross PL. Rivaroxaban Efficacy and Safety in SELECT-D Community Cancer-Associated Venous Thromboembolism Patients. JACC CardioOncol. 2023 Feb 7;5(2):201-202. doi: 10.1016/j.jaccao.2022.12.006. eCollection 2023 Apr.
	35363452	0	Devereaux PJ, Marcucci M, Painter TW, et al. Tranexamic Acid in Patients Undergoing Noncardiac Surgery. N Engl J Med. 2022 Apr 2. doi: 10.1056/NEJMoa2201171.
	35362102	0	Schulman S, Carlson V, Serrano PE, et al. Adherence to apixaban for extended thromboprophylaxis after major abdominal or pelvic surgery for cancer: A prospective cohort study. J Surg Oncol. 2022 Apr 1. doi: 10.1002/jso.26876.
	34939141	0	Bartoszko J, Li H, Fitzgerald J, et al. The association of thrombin generation with bleeding outcomes in cardiac surgery: a prospective observational study. Can J Anaesth. 2022 Mar;69(3):311-322. doi: 10.1007/s12630-021-02165-1. Epub 2021 Dec 22.
	34852380	0	Makedonov I, Kahn SR, Abdulrehman J, et al. Prevention of the post thrombotic syndrome with anticoagulation: a narrative review. Thromb Haemost. 2021 Dec 1. doi: 10.1055/a-1711-1263.
	34556452	0	Violette PD, Cartwright R, Devereaux PJ, et al. ARTS: A Large, International Trial of Thromboprophylaxis in Intra-abdominal, Gynecologic, and Urologic Surgery. Eur Urol Focus. 2021 Sep 21. pii: S2405-4569(21)00225-X. doi: 10.1016/j.euf.2021.08.010.
	34351722	0	Goligher EC, Bradbury CA, McVerry BJ, et al. Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19. N Engl J Med. 2021 Aug 26;385(9):777-789. doi: 10.1056/NEJMoa2103417. Epub 2021 Aug 4.
	34351721	0	Lawler PR, Goligher EC, Berger JS, et al. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19. N Engl J Med. 2021 Aug 26;385(9):790-802. doi: 10.1056/NEJMoa2105911. Epub 2021 Aug 4.
	34334192	0	Ho LTS, McVey MJ, Kuiper GJAJM, et al. Analysis of the effect of varying protamine-to-heparin ratio on coagulation in vitro. Br J Anaesth. 2021 Oct;127(4):e128-e130. doi: 10.1016/j.bja.2021.06.037. Epub 2021 Jul 30.
	33872825	0	Carlin S, Bond A, Gross P, et al. Initiation of anticoagulation in atrial fibrillation by primary care physicians: Results of a telephone survey. Thromb Res. 2021 Jun;202:176-181. doi: 10.1016/j.thromres.2021.04.004. Epub 2021 Apr 15.
	33826233	0	Juneja GK, Castelo M, Yeh CH, et al. Biomarkers of coagulation, endothelial function, and fibrinolysis in critically ill patients with COVID-19: A single-center prospective longitudinal study. J Thromb Haemost. 2021 Jun;19(6):1546-1557. doi: 10.1111/jth.15327. Epub 2021 May 1.
	33585495	0	Gross PL, Chan NC. Thromboembolism in Older Adults. Front Med (Lausanne). 2021 Jan 27;7:470016. doi: 10.3389/fmed.2020.470016. eCollection 2020.
	32815416	0	Houston BL, Lawler PR, Goligher EC, et al. Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial. Clin Trials. 2020 Oct;17(5):491-500. doi: 10.1177/1740774520943846. Epub 2020 Aug 20.
	32762455	0	Siegal DM, Gross PL. Narrowing in on the True Rate of Venous Thromboembolism in Hospitalized Patients With COVID-19 Disease. Arterioscler Thromb Vasc Biol. 2020 Sep;40(9):1958-1960. doi: 10.1161/ATVBAHA.120.314977. Epub 2020 Jul 30.
	32506822	0	Ni R, Neves MAD, Wu C, et al. Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) attenuates fibrin-dependent plasmin generation on thrombin-activated platelets. J Thromb Haemost. 2020 Sep;18(9):2364-2376. doi: 10.1111/jth.14950.
	32133581	0	Fitzgerald J, McMonnies R, Sharkey A, et al. Thrombin generation and bleeding in cardiac surgery: a clinical narrative review. Can J Anaesth. 2020 Jun;67(6):746-753. doi: 10.1007/s12630-020-01609-4. Epub 2020 Mar 4.
	31380891	0	Douketis JD, Spyropoulos AC, Duncan J, et al. Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant. JAMA Intern Med. 2019 Nov 1;179(11):1469-1478. doi: 10.1001/jamainternmed.2019.2431.
	31005064	0	Shaya SA, Gani DM, Weitz JI, et al. Factor XIII Prevents Pulmonary Emboli in Mice by Stabilizing Deep Vein Thrombi. Thromb Haemost. 2019 Jun;119(6):992-999. doi: 10.1055/s-0039-1685141. Epub 2019 Apr 20.
	30985986	0	Kim PY, Di Giuseppantonio LR, Wu C, et al. An assay to measure levels of factor Xa inhibitors in blood and plasma. J Thromb Haemost. 2019 Jul;17(7):1153-1159. doi: 10.1111/jth.14451. Epub 2019 May 10.
	30760422	0	Lee H, Tan MK, Yan AT, et al. Association Between Patient and Physician Sex and Physician-Estimated Stroke and Bleeding Risks in Atrial Fibrillation. Can J Cardiol. 2019 Feb;35(2):160-168. doi: 10.1016/j.cjca.2018.11.023. Epub 2018 Dec 3.
	30511879	0	Carrier M, Abou-Nassar K, Mallick R, et al. Apixaban to Prevent Venous Thromboembolism in Patients with Cancer. N Engl J Med. 2019 Feb 21;380(8):711-719. doi: 10.1056/NEJMoa1814468. Epub 2018 Dec 4.
	30354213	0	Ni R, Vaezzadeh N, Zhou J, et al. Effect of Different Doses of Acetylsalicylic Acid on the Antithrombotic Activity of Clopidogrel in a Mouse Arterial Thrombosis Model. Arterioscler Thromb Vasc Biol. 2018 Oct;38(10):2338-2344. doi: 10.1161/ATVBAHA.118.311404.
	29564837	0	Schulman S, Gross PL, Ritchie B, et al. Prothrombin Complex Concentrate for Major Bleeding on Factor Xa Inhibitors: A Prospective Cohort Study. Thromb Haemost. 2018 May;118(5):842-851. doi: 10.1055/s-0038-1636541. Epub 2018 Mar 21.
	29466159	0	Anderson DR, Dunbar M, Murnaghan J, et al. Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty. N Engl J Med. 2018 Feb 22;378(8):699-707. doi: 10.1056/NEJMoa1712746.
	29353682	0	van Es N, Louzada M, Carrier M, et al. Predicting the risk of recurrent venous thromboembolism in patients with cancer: A prospective cohort study. Thromb Res. 2018 Mar;163:41-46. doi: 10.1016/j.thromres.2018.01.009. Epub 2018 Jan 9.
	29212129	0	Douketis JD, Spyropoulos AC, Anderson JM, et al. The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant Who Need an Elective Surgery or Procedure: Design and Rationale. Thromb Haemost. 2017 Dec;117(12):2415-2424. doi: 10.1160/TH17-08-0553. Epub 2017 Dec 6.
	28894738	0	Smrke A, Gross PL. Cancer-Associated Venous Thromboembolism: A Practical Review Beyond Low-Molecular-Weight Heparins. Front Med (Lausanne). 2017 Aug 28;4:142. doi: 10.3389/fmed.2017.00142. eCollection 2017.
	27780803	0	Fredenburgh JC, Gross PL, Weitz JI. Emerging anticoagulant strategies. Blood. 2017 Jan 12;129(2):147-154. doi: 10.1182/blood-2016-09-692996. Epub 2016 Oct 25.
	27126647	0	Jagadeeswaran P, Cooley BC, Gross PL, et al. Animal Models of Thrombosis From Zebrafish to Nonhuman Primates: Use in the Elucidation of New Pathologic Pathways and the Development of Antithrombotic Drugs. Circ Res. 2016 Apr 29;118(9):1363-79. doi: 10.1161/CIRCRESAHA.115.306823.
	26879070	0	Bell AD, Gross P, Heffernan M, et al. Appropriate Use of Antithrombotic Medication in Canadian Patients With Nonvalvular Atrial Fibrillation. Am J Cardiol. 2016 Apr 1;117(7):1107-11. doi: 10.1016/j.amjcard.2015.12.055. Epub 2016 Jan 14.
	25727083	0	Patel AD, Tan MK, Angaran P, et al. Risk stratification and stroke prevention therapy care gaps in Canadian atrial fibrillation patients (from the Co-ordinated National Network to Engage Physicians in the Care and Treatment of Patients With Atrial Fibrillation chart audit). Am J Cardiol. 2015 Mar 1;115(5):641-6. doi: 10.1016/j.amjcard.2014.12.022. Epub 2014 Dec 18.
	25691157	0	Vu TT, Zhou J, Leslie BA, et al. Arterial thrombosis is accelerated in mice deficient in histidine-rich glycoprotein. Blood. 2015 Apr 23;125(17):2712-9. doi: 10.1182/blood-2014-11-611319. Epub 2015 Feb 17.